Precision targeted therapy of ovarian cancer

Justin Sapiezynski1, Oleh Taratula2, Lorna Rodriguez-Rodriguez3

  • 1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, United States.

Insights

This review covers advanced ovarian cancer detection and personalized treatments. It highlights nanotechnology for targeted therapies, offering future directions in precision medicine.

Area of Science:

  • Oncology
  • Nanotechnology
  • Precision Medicine

Background:

  • Ovarian cancer remains a significant health challenge with a need for improved detection and treatment strategies.
  • Current therapeutic approaches often lack specificity, leading to side effects and limited efficacy.
  • The integration of nanotechnology offers promising avenues for enhancing ovarian cancer management.

Purpose of the Study:

  • To review contemporary methods for ovarian cancer detection.
  • To discuss precision and personalized treatment strategies for ovarian cancer.
  • To explore the role and future potential of nanotechnology in targeted ovarian cancer therapy.

Main Methods:

  • Literature review of recent advancements in ovarian cancer diagnostics.
  • Analysis of current precision medicine approaches in oncology.
  • Examination of nanotechnology applications in targeted cancer therapy research.

Main Results:

  • Modern diagnostic techniques are improving early detection rates.
  • Personalized treatment plans are enhancing patient outcomes.
  • Nanotechnology-based therapies show potential for targeted drug delivery and reduced toxicity.

Conclusions:

  • Advancements in detection and personalized medicine are crucial for combating ovarian cancer.
  • Nanotechnology presents a transformative approach for targeted and precise ovarian cancer treatments.
  • Further research into nanotechnology is essential to realize its full clinical potential.